Journal Study Dec 29, 2022 Study Shows Potential of Drug Sensitivity Profiling With Sequencing for Pediatric Cancers Dec 20, 2022 Multiomic Study Points to New Colorectal Cancer Risk Contributors Dec 12, 2022 T-Cell Subpopulations in Blood May Help Predict Immune Checkpoint Immunotherapy Side Effects Dec 1, 2022 Study Unearths Features Found in Long-Term Survivors of Advanced Ovarian Cancer Nov 28, 2022 Studies Assess Tumor Aneuploidy to Guide Immunotherapy Treatment Nov 10, 2022 Cancer Patients in Early Trial Receive Personalized, CRISPR-Edited T-Cell Therapy Oct 27, 2022 Immunotherapy Response Features Identified in Pancreatic Cancer Microenvironment Oct 17, 2022 Polygenic Risk Scores Could Refine Breast Cancer Screening Recommendations Premium Sep 30, 2022 Tumor-Only Sequencing Found to Overestimate Mutational Burden in Non-European Patients Sep 22, 2022 Universal Genetic Testing in Breast Cancer Further Supported in New Invitae-Led Study Sep 7, 2022 Head and Neck Cancer Treatment Targets, Biomarkers Unearthed in Cell Model Analyses Aug 8, 2022 Small Cell Lung Cancer Detection, Classification Achieved Using Cell-Free DNA Methylation Aug 5, 2022 Chronic Lymphocytic Leukemia Genomic Study Reveals New Subtypes, Ties to Outcomes Aug 4, 2022 PTEN Mutation Syndrome Leads to Breast Cancers With Distinct Molecular Alterations Jul 20, 2022 Treatment-Resistant Prostate Cancer Clues Drawn From Circulating Tumor DNA Dynamics Breaking News Flare Therapeutics Raises $123M in Oversubscribed Series B Funding Round William Blair Initiates Coverage of MDxHealth With Outperform Rating White House Report Outlines Goals to Advance Genomic Research, Precision Therapy Development In Brief This Week: Fore Biotherapeutics, RayzeBio, Gilead Sciences, Atossa Therapeutics Bayer to Assess Nubeqa in High-Risk, Early-Stage Hormone-Sensitive Prostate Cancer BridgeBio Begins Phase I/II Study of SHP2 Inhibitor, Opdivo in KRAS-Mutant Solid Tumors